Dr. Fysal Albaalbaki, MD

Dr. Albaalbaki practices at Dialysis Care of Weatherford in Hudson Oaks, Texas.

Dr. Albaalbaki's NPI, 1548449663, was assigned on October 25, 2007. Dr. Albaalbaki graduated from Damascus University Faculty of Medicine in 2000. Dr. Albaalbaki's Texas license number on file is Q9273.

Dr. Albaalbaki's primary practice is Dialysis Care of Weatherford, at 2702 Ft Worth Hwy, Hudson Oaks, TX 76087 in Parker County. The practice phone is (817) 599-6954.

Dr. Albaalbaki's primary practice is Dialysis Care of Weatherford in Hudson Oaks, Texas. Dr. Albaalbaki is also affiliated with Texas Health Fort Worth. The medical group on file is Texas Health Care. Dmand AI also links Dr. Albaalbaki to 4 more hospitals, 4 dialysis centers, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Albaalbaki practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Albaalbaki's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Albaalbaki is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Albaalbaki's licenses on file in 4 states: Texas, Tennessee, Arizona and Ohio.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, kidney cysts and parathyroid gland disorder among the conditions Dr. Albaalbaki treats.

CMS data shows 1,933 Medicare services from Dr. Albaalbaki across 12 procedure codes in 2024, for 530 Medicare patients. Medicare paid $195,518 for them.

CMS counts 530 Medicare patients who saw Dr. Albaalbaki in 2024. The largest group is 75 to 84, with 202 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 15% are also on Medicaid. Their average risk score is 3.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Albaalbaki's median patient age at 73, with 50% women.

In 2024, Dr. Albaalbaki wrote 2,040 Medicare Part D claims for 402 patients. 86% of them were for generic drugs. CMS names the drug for 1,766 of them, across 35 drugs with 11 or more claims each, at $211,256 in total drug cost. In 2023, CMS named 1,624 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Albaalbaki for performance year 2024, reported through an alternative payment model (APM). Dr. Albaalbaki accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Albaalbaki in 2021. Dr. Albaalbaki's most frequent co-authors are Hangameh Dehbozorgi, DO, Quy Nguyen Lam, MD and Alexandra M. Villacres, MD.

CMS Open Payments shows 9 general payments to Dr. Albaalbaki from 7 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 93% of the total. AstraZeneca Pharmaceuticals LP paid the most, $140.

Dr. Albaalbaki graduated from Damascus University Faculty of Medicine in 2000.

Dr. Albaalbaki is in network with 20 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.